Browsing: Novo

This article was written byFollowJR Research is an opportunistic investor. I was recognized by TipRanks as a Top Analyst, and also by Seeking Alpha as a…

This article was written byFollowThe Edson Spencer Professor of Strategy and Technological Leadership at the University of Minnesota Carlson School of Management Alfred Marcus’ most recent…

Novo Nordisk’s plan to gain ground in the GLP-1 space is slowly taking shape.Ozempic has been one of Novo Nordisk’s (NVO +1.27%) main growth drivers for…

This article was written byFollowFirst Principles Partners is an equity research analyst specializing in technology, innovation, and sustainability investment. My unique approach, “First Principles,” involves breaking…

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Nov. 24, 2025.Tom Little |…

Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images)Ucg | Universal…

Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood sugar. (Photo by Steve Christo – Corbis/Corbis via…

This article was written byFollowWith a background as a RN, I analyze healthcare-related stocks by evaluating clinical data, treatment guidelines, and market dynamics. After completing my…

This article was written byFollowJR Research is an opportunistic investor. He was recognized by TipRanks as a Top Analyst. He was also recognized by Seeking Alpha…

Key Takeaways Novo Nordisk shares soared Tuesday after the company said the Food and Drug Administration approved an oral version of its popular Wegovy weight-loss drug.The…